Acquired cisplatin resistance in the hea
โ
Eva M. Gosepath; Niels Eckstein; Alexandra Hamacher; Kati Servan; Georg von Jonq
๐
Article
๐
2008
๐
John Wiley and Sons
๐
French
โ 301 KB
๐ 1 views
## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatinโbased chemotherapy, mostly in combination with 5โFU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes